1. Home
  2. BARK vs TIL Comparison

BARK vs TIL Comparison

Compare BARK & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

N/A

Current Price

$0.63

Market Cap

92.7M

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$8.42

Market Cap

74.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BARK
TIL
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
74.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BARK
TIL
Price
$0.63
$8.42
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$2.50
$125.00
AVG Volume (30 Days)
893.9K
21.1K
Earning Date
02-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
52.54
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$5.67
52 Week High
$1.48
$42.75

Technical Indicators

Market Signals
Indicator
BARK
TIL
Relative Strength Index (RSI) 28.04 48.96
Support Level $0.53 $8.14
Resistance Level $0.86 $9.27
Average True Range (ATR) 0.05 0.45
MACD -0.02 -0.04
Stochastic Oscillator 8.88 36.18

Price Performance

Historical Comparison
BARK
TIL

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: